Amplification of c-myc, K-sam, and c-met in gastric cancers: Detection by fluorescence in situ hybridization

Laboratory Investigation

Volumn 78, Issue 9, 1998, Pages 1143-1153

  Hara, Takuo ^a   Ooi, Akishi ^a,c   Kobayashi, Masako ^a   Mai, Masayoshi ^a   Yanagihara, Kazuyoshi ^b   Nakanishi, Isao ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS;

BLOTTING, SOUTHERN; CELL NUCLEUS; FIXATIVES; FORMALDEHYDE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; REFERENCE VALUES; STOMACH NEOPLASMS;

EID: 0031657056     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bar-Am I, Mor O, Yeger H, Shiloh Y, and Avivi L (1992). Detection of amplified DNA sequences in human tumor cell lines by fluorescence in situ hybridization. Genes Chromosom Cancer 4:314-320.
2. Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter H, Lenoir G, and Leder P (1983). The human c-myc oncogene: Structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34:779-787.
3. Coene ED, Schelfhout V, Winkler RA, Schelfhout AM, Van Roy N, Grooteclaes M, Speleman F, and De Potter CR (1997). Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer. Virchows Arch 430:365-372.
4. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, and Vande Woude GF (1984). Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29-33.
5. Cooper CS, Tempest PR, Beckman MP, Heldin CH, and Brookes P (1986). Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts. EMBO J 5:2623-2628.
6. Dang CV (1991). c-Myc oncoprotein function. Biochim Biophys Acta 1072:103-113.
7. DePinho RA, Schreiber-Agus N, and Alt FW (1991). myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57:1-46.
8. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, and Comoglio PM (1989). Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339:155-156.
9. Gutman M, Ravia Y, Assaf D, Yamamoto T, Rozin R, and Shiloh Y (1989). Amplification of c-myc and c-erbB-2 protooncogenes in human solid tumors: Frequency and clinical significance. Int J Cancer 44:802-805.
10. Hattori Y, Itoh H, Uchino S, Hosokawa K, Ochiai A, Ino Y, Ishii H, Sakamoto H, Yamaguchi N, Yanagihara K, Hirohashi S, Sugimura T, and Terada M (1998). Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 2:1373-1381.
11. Hudziak RM, Lewis GD, Holmes WE, Ullrich A, and Shepard HM (1990). Selection for transformation and met protooncogene amplification in NIH3T3 fibroblasts using tumor necrosis factor alpha. Cell Growth Differ 1:129-134.
12. Ishikawa T, Kobayashi M, Mai M, Suzuki T, and Ooi A (1997). Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells: Detection by fluorescence in situ hybridization. Am J Pathol 151:761-768.
13. Itoh H, Hattori Y, Sakamoto H, Ishii H, Kishi T, Sasaki H, Yoshida T, Koono M, Sugimura T, and Terada M (1994). Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity. Cancer Res 54:3237-3241.
14. Japanese Research Society for Gastric Cancer (1981a). The general rules for the gastric cancer study in surgery and pathology: Part I - Clinical classification. Jpn J Surg 11: 127-139.
15. Japanese Research Society for Gastric Cancer Committee on Histologic Classification of Gastric Cancer (1981b). The General rules for the gastric cancer study in surgery and pathology: Part II - Histological classification of gastric cancer. Jpn J Surg 11:140-145.
16. Kobayashi M, Kawashima A, Mai M, and Ooi A (1996). Analysis of chromosome 17p13 (p53locus) alteration in gastric carcinoma cells by dual color fluorescence in situ hybridization. Am J Pathol 149:1575-1584.
17. Koda T, Matsushima S, Sasaki A, Danjo Y, and Kakinuma M (1985). c-myc gene amplification in primary stomach cancer. Jpn J Cancer Res 76:551-554.
18. Mor O, Messinger Y, Rotman G, Bar-Am I, Ravia Y, Eddy RL, Shows TB, Park JG, Gazdar AF, and Shiloh Y (1991). Novel DNA sequences at chromosome 10q26 are amplified in human gastric carcinoma cell lines: Molecular cloning by competitive DNA reassociation. Nucleic Acids Res 19: 117-123.
19. Motoyama T, Hojo H, and Watanabe H (1986). Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36:65-83.
20. Nakasato F, Sakamoto H, Mori M, Hayashi K, Shimosato Y, Nishi M, Takao S, Nakatani K, Terada M, and Sugimura T (1984). Amplification of the c-myc oncogene in human stomach cancers. Gann 75:732-742.
21. Nakatani H, Sakamoto H, Yoshida T, Yokota J, Tahara E, Sugimura T, and Terada M (1990). Isolation of an amplified DNA sequences in stomach cancer. Jpn J Cancer Res 81:707-719.
22. Nakatani H, Tahara E, Yoshida T, Sakamoto H, Suzuki T, Watanabe H, Sekiguchi M, Kaneko Y, Sakurai M, Terada M, and Sugimura T (1986). Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Jpn J Cancer Res 77:849-853.
23. Nomura N, Yamamoto T, Toyoshima K, Ohami H, Akimaru K, Sasaki S, Nakagami Y, Kanauchi H, Shoji T, Hiraoka Y, Matsui M, and Ishizaki R (1986). DNA amplification of the c-myc and c-erbB-1 genes in human stomach cancer. Jpn J Cancer Res 77:1188-1192.
24. Ooi A, Kobayashi M, Mai M, and Nakanishi I (1998). Amplification of c-erbB-2 in gastric cancer: Detection in formalin-fixed paraffin-embedded tissue by fluorescence in situ hybridization. Lab Invest 78:345-351.
25. Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE, Bang YJ, Kim JP, and Gazdar AF (1990). Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50:2773-2780.
26. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, and Vande Woude GF (1986). Mechanism of met oncogens activation. Cell 45:895-904.
27. Ponzetto C, Giordano S, Peverali F, Della Valle G, Abate ML, Vaula G, and Comoglio PM (1991). c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6:553-559.
28. Sambrook J, Fritsch EF, and Maniatis T (1989). Molecular cloning. In: A laboratory manual, 2nd ed. New York: Cold Spring Harbor Lab.
29. Sekiguchi M, Sakakibara K, and Fujii G (1978). Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48:61-68.
30. Seruca R, Castedo S, Correia C, Gomes P, Carneiro F, Soares P, de Jong B, and Sobrinho-Simoes M (1993). Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet 68:42-48.
31. Seruca R, Suijkerbuijk RF, Gartner F, Criado B, Veiga I, Olde-weghuis D, David L, Castedo S, and Sobrinbo-Simoes M (1995). Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet Cytogenet 82:140-145.
32. Shibuya M, Yokota J, and Ueyama Y (1985). Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Moll Cell Biol 5:414-418.
33. Taya Y, Hosogai K, Hirohashi S, Shimosato Y, Tsuchiya R, Tsuchida N, Fushimi M, Sekiya T, and Nishimura S (1984). A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J 3:2943-2946.
34. Tsuchiya T, Ueyama Y, Tamaoki N, Yamaguchi S, and Shibuya M (1989). Co-amplifcation of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer. Jpn J Cancer Res 80:920-923.
35. Tsuchiya T, Ueyama Y, Tamaoki N, Yamaguchi S, and Shibuya M (1989). Co-amplification of c-myc and c-erb-2 oncogenes in a poorly differentiated human gastric cancer. Jpn J Cancer Res 80:920-923.
36. Tsujimoto H, Sugihara H, Hagiwara A, and Hattori T (1997). Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer. Virchows Arch 431:383-389.
37. Yanagihara K, Seyama T, Tsumuraya M, Kameda N, and Yokoro K (1991). Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51:381-386.
38. Yokota J, Tsunetsugu-Yokota Y, Battifora H, Le Fevre C, and Cline MJ (1986). Alterations of myc, mub, and rasHa protooncogenes in cancers are frequent and show clinical correlation. Science 231:261-264.
39. Yoshida K, Tsuda T, Matsumura T, Tsujino T, Hattori T, Ito H, and Tahara E (1989). Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch B 57:285-290.